Insider Trading Alert - SUBK, CNMD And BPOP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 29, 2015, 92 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $125.13 to $236,025,000.00.

Highlighted Stocks Traded by Insiders:

Suffolk Bancorp (SUBK) - FREE Research Report

Danowski James E, who is Director at Suffolk Bancorp, bought 46 shares at $23.60 on May 29, 2015. Following this transaction, the Director owned 37,637 shares meaning that the stake was boosted by 0.12% with the 46-share transaction.

Filipo Frank D, who is EVP & Chief Operating Officer at Suffolk Bancorp, bought 5 shares at $23.60 on May 29, 2015. Following this transaction, the EVP & Chief Operating Officer owned 9,143 shares meaning that the stake was boosted by 0.06% with the 5-share transaction.

Gaviola Joseph A, who is Director at Suffolk Bancorp, bought 13 shares at $23.60 on May 29, 2015. Following this transaction, the Director owned 6,233 shares meaning that the stake was boosted by 0.21% with the 13-share transaction.

The shares most recently traded at $23.90, up $0.30, or 1.25% since the insider transaction. Historical insider transactions for Suffolk Bancorp go as follows:

  • 4-Week # shares bought: 200
  • 12-Week # shares bought: 400
  • 24-Week # shares bought: 1,444

The average volume for Suffolk Bancorp has been 15,600 shares per day over the past 30 days. Suffolk Bancorp has a market cap of $284.3 million and is part of the financial sector and banking industry. Shares are up 6.21% year-to-date as of the close of trading on Friday.

Suffolk Bancorp operates as the holding company for Suffolk County National Bank that provides commercial and retail banking services primarily in Nassau and Suffolk counties, New York. The company's deposit products include demand, saving, N.O.W., money market, and time deposits. The stock currently has a dividend yield of 0.99%. The company has a P/E ratio of 18.2. Currently, there is 1 analyst who rates Suffolk Bancorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SUBK - FREE

TheStreet Quant Ratings rates Suffolk Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Suffolk Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Conmed (CNMD) - FREE Research Report

Mandia Stephen, who is Director at Conmed, sold 14,000 shares at $55.62 on May 29, 2015. Following this transaction, the Director owned 1 shares meaning that the stake was reduced by 100% with the 14,000-share transaction.

The shares most recently traded at $55.66, up $0.04, or 0.07% since the insider transaction. Historical insider transactions for Conmed go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 4,500
  • 12-Week # shares bought: 5,235
  • 12-Week # shares sold: 8,399
  • 24-Week # shares bought: 5,235
  • 24-Week # shares sold: 8,399

The average volume for Conmed has been 145,000 shares per day over the past 30 days. Conmed has a market cap of $1.5 billion and is part of the health care sector and health services industry. Shares are up 23.53% year-to-date as of the close of trading on Friday.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures and monitoring in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. The stock currently has a dividend yield of 1.43%. The company has a P/E ratio of 51.7. Currently, there are 4 analysts who rate Conmed a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNMD - FREE

TheStreet Quant Ratings rates Conmed as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Conmed Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Popular (BPOP) - FREE Research Report

Sepulveda Eli, who is Evp at Popular, sold 6,100 shares at $32.49 on May 29, 2015. Following this transaction, the Evp owned 27,608 shares meaning that the stake was reduced by 18.1% with the 6,100-share transaction.

The shares most recently traded at $32.39, down $0.10, or 0.31% since the insider transaction. Historical insider transactions for Popular go as follows:

  • 4-Week # shares sold: 16,092
  • 12-Week # shares sold: 23,670
  • 24-Week # shares sold: 23,670

The average volume for Popular has been 752,600 shares per day over the past 30 days. Popular has a market cap of $3.4 billion and is part of the financial sector and banking industry. Shares are down 4.58% year-to-date as of the close of trading on Friday.

Popular, Inc., through its subsidiaries, provides various retail and commercial banking products and services primarily to institutional and retail customers. The company accepts various deposit products. Currently, there is 1 analyst who rates Popular a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BPOP - FREE

TheStreet Quant Ratings rates Popular as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, expanding profit margins and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and deteriorating net income. Get the full Popular Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Insider Trading Alert - NHI, SUBK And EXPO Traded By Insiders

Insider Trading Alert - NHI, SUBK And EXPO Traded By Insiders

Insider Trading Alert - SUBK, ISIG And SNBC Traded By Insiders

Insider Trading Alert - SUBK, ISIG And SNBC Traded By Insiders

Suffolk Bancorp About To Put More Money In Your Pocket (SUBK)

Suffolk Bancorp About To Put More Money In Your Pocket (SUBK)

Insider Trading Alert - SUBK, PDCO And MNTA Traded By Insiders

Insider Trading Alert - SUBK, PDCO And MNTA Traded By Insiders